Multidomain peptide hydrogel adjuvants elicit strong bias towards humoral immunity-Reference-Cited by-同舟云学术

Multidomain peptide hydrogel adjuvants elicit strong bias towards humoral immunity

Published:2022 Issue:21 Volume:10 Page:6217-6229
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Pogostin Brett H.¹^ORCID,Yu Marina H.¹,Azares Alon R.²,Euliano Erin M.¹,Lai Cheuk Sun Edwin¹,Saenz Gabriel³,Wu Samuel X.¹,Farsheed Adam C.¹,Melhorn Sarah M.¹,Graf Tyler P.¹,Woodside Darren G.²,Hartgerink Jeffrey D.¹³^ORCID,McHugh Kevin J.¹^ORCID

Affiliation:

1. Department of Bioengineering, Rice University, Houston, TX, 77005, USA

2. Molecular Cardiology Research Laboratories, Texas Heart Institute, Houston, TX, 77030, USA

3. Department of Chemistry, Rice University, Houston, TX, 77005, USA

Abstract

Self-assembling multidomain peptide hydrogels direct a nearly exclusive humoral adaptive immune response compared to alum, the most widely used adjuvant in vaccines.

Funder

National Science Foundation

National Institutes of Health

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2022/BM/D2BM01242A

Reference62 articles.

1. Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study

2. Cancer vaccine adjuvants – recent clinical progress and future perspectives